Long-Read Sequencing Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Long-Read Sequencing Market Increase Between 2026 And 2030?

The long-read sequencing market size has experienced substantial expansion in recent years. It is anticipated to increase from $1.15 billion in 2025 to $1.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.8%. The historic period’s growth can be attributed to several factors, including the constraints of short-read sequencing, the rise of genomics research, significant technological innovations in nanopore sequencing, the requirement for precise genome assembly, and increased financial support within the life sciences sector.

The long-read sequencing market size is anticipated to experience substantial growth in the coming years, projected to reach $3.74 billion by 2030 at a compound annual growth rate (CAGR) of 26.5%. This expansion during the forecast period can be attributed to factors such as the clinical adoption of long-read sequencing, falling sequencing costs, its integration with AI-based analysis, increased application in oncology diagnostics, and the development of population genomics. Key trends for the forecast period encompass the increasing uptake of long-read technologies, enhanced structural variant detection, the emergence of hybrid sequencing approaches, expanded use in rare disease genomics, and a rising application in complex genome assembly.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28259&type=smp

Which Strategic Drivers Are Supporting The Long-Read Sequencing Market Development?

The anticipated rise in genetic disease cases is set to boost the expansion of the long-read sequencing market in the future. These conditions stem from alterations or mutations in DNA, either inherited or spontaneous, impacting health, development, or bodily functions. This growing occurrence is linked to enhanced awareness and progress in diagnostic tools, facilitating earlier and more precise identification of conditions previously undetected. Long-read sequencing improves the management of genetic disorders by offering highly accurate and thorough genomic data, making it suitable for diagnosing intricate and uncommon conditions. It minimizes diagnostic ambiguity through the identification of structural variations and complex mutations, thereby refining personalized treatment strategies and clinical choices. For example, as reported by the Cystic Fibrosis Trust, a national charity in the UK, in October 2024, the number of individuals living with cystic fibrosis (CF) in the UK was 11,148 in 2022, rising to 11,318 in 2023. Consequently, the growing incidence of genetic diseases is a key factor propelling the expansion of the long-read sequencing market.

Which Segment-Based Categories Are Covered In The Long-Read Sequencing Market?

The long-read sequencing market covered in this report is segmented –

1) By Product And Service: Instruments Or Platforms, Consumables And Reagents, Services And Software

2) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

3) By Technology Platform: Single Molecule Real-Time (SMRT) High-Fidelity (HiFi) Sequencing, Synthetic Long-Read Or Linked-Read, Hybrid And Other Emerging

4) By Application: Human Genomics And Rare-Disease Diagnostics, Oncology And Liquid Biopsy, Metagenomics And Microbiome, Transcriptomics, Agri Genomics And Plant Or Animal Breeding, Other Applications

5) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Uses

Subsegments:

1) By Instruments Or Platforms: Single-Molecule Real-Time (SMRT) Sequencers, Nanopore Sequencers

2) By Consumables And Reagents: Library Preparation Kits, Sample Preparation Kits, Sequencing Kits

3) By Services And Software: Sequencing Services, Data Analysis Services, Bioinformatics Software

Which Trends Are Affecting The Long-Read Sequencing Market Framework?

Leading companies within the long-read sequencing market are directing their efforts toward developing innovative solutions, including HiFi reads, to enhance the accuracy of sequencing, detect complex genetic variations, and accelerate genomic research. High-fidelity (HiFi) reads denote lengthy DNA sequences generated by particular long-read sequencing technologies, which offer both extensive read lengths and exceptionally low error rates, thus enabling the precise detection of intricate genetic and structural variants. For example, in November 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, launched its Vega system, marking its inaugural benchtop long-read sequencing platform designed for more rapid and accessible genomic analysis. This compact and affordable benchtop long-read sequencer delivers highly accurate HiFi data, boasting 99.9% read accuracy. It facilitates fast, versatile sequencing for various applications such as RNA, targeted, and small genome sequencing, making advanced genomics capabilities available to a greater number of laboratories. The Vega system simplifies workflows with its onboard computing and ease of operation, empowering researchers to efficiently uncover complex genetic insights.

Which Companies Are Engaged In The Long-Read Sequencing Market Environment?

Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG

Access The Complete Long-Read Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-global-market-report

Which Region Commands The Largest Share Of The Long-Read Sequencing Market?

North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Long-Read Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-global-market-report

Browse Through More Reports Similar to the Global Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795